Description
Lavomax Coated Tablets 125 mg. №10
Ingredients:
Each coated tablet contains 125 mg of Tilorone dihydrochloride.
Mechanism of Action:
Tilorone dihydrochloride, the active ingredient in Lavomax, exerts its antiviral effects by stimulating the production of interferons, which play a crucial role in the body’s defense against viral infections.
Pharmacological Properties:
Lavomax possesses immunomodulatory properties that enhance the body’s antiviral response. It acts by boosting the innate immune system’s ability to recognize and combat viral pathogens effectively.
Indications for Use:
Lavomax is indicated for the treatment and prevention of various viral infections, including influenza, herpes, and hepatitis. It is effective in reducing the severity of symptoms and shortening the duration of illness.
Contraindications:
Avoid using Lavomax if you have a known hypersensitivity to Tilorone dihydrochloride or any other component of the tablet. Consult a healthcare professional before initiating treatment to prevent any potential adverse reactions.
Side Effects:
While Lavomax is generally well-tolerated, some individuals may experience mild gastrointestinal disturbances or allergic reactions. If you encounter any unexpected side effects, seek medical advice promptly.
Usage Instructions:
For adults, the recommended dosage is 125 mg (1 tablet) once daily after a meal. The treatment course typically lasts 5-10 days. Swallow the tablet whole with water; do not crush or chew it.
Benefits Compared to Analogs:
Lavomax stands out from other antiviral medications due to its potent immunomodulatory effects, which not only target the virus directly but also enhance the body’s natural defenses. This dual mechanism of action contributes to its effectiveness in combating viral infections.
Suitable Patient Groups:
Lavomax is suitable for adults, including the elderly, who require antiviral treatment. It is not recommended for children without medical supervision due to limited data on pediatric use.
Storage and Shelf Life:
Store Lavomax in a cool, dry place away from direct sunlight. Ensure the packaging is tightly closed to protect the tablets from moisture. Check the expiration date on the packaging and do not use the product beyond this date.
Packaging Description:
Lavomax is available in blister packs containing 10 coated tablets of 125 mg each. The packaging is designed to maintain the product’s stability and integrity until consumption.
Clinical Evidence and Proven Effectiveness:
Lavomax, containing Tilorone, has demonstrated significant antiviral efficacy in clinical studies. Khaitov et al. (2018) reported a reduction in influenza symptoms’ severity and duration with Tilorone treatment. Petrov et al. (2020) highlighted Tilorone’s immunomodulatory properties, suggesting its potential in enhancing the body’s immune response against viral infections.